Clinical Trials Directory

Trials / Completed

CompletedNCT06340087

Impact Hesperetin in Combination with Sucrose on Blood Glucose Regulation

Einfluss Des Süßmodulierenden Polyphenols Hesperetin in Kombination Mit Saccharose Auf Die Blutglukose-Regulierung Und Energieaufnahme in Abhängigkeit Der Süßwahrnehmung Teil 2

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
39 (actual)
Sponsor
University of Vienna · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The aim of this cross-over intervention study is to investigate the influence of hesperetin applied in combination with sucrose in comparison to an equally sweet-tasting sucrose-only solution and an isocaloric sucrose-only solution on markers of energy metabolism

Detailed description

The study is designed as a randomised cross-over intervention study with three arms. The aim is to investigate the influence of a 10% sucrose solution, corresponding to the sugar content of a conventional soft drink, compared to an equally sweet-tasting 7% sucrose solution in combination with 50 mg/L of the polyphenol hesperetin, and a less sweet 7% sucrose solution w/o hesperetin on time-dependent blood glucose fluctuations and ad libitum energy intake in metabolically healthy male volunteers. To investigate the underlying mechanisms, the individual appetite score, metabolic and hormonal responses to the interventions and will be measured. In addition, the participants' individual thresholds for sweet taste, preference and consumption for sweet-tasting foods such as sugar and sweeteners, and their body composition will be recorded as potential influencing factors.

Conditions

Interventions

TypeNameDescription
OTHER10% Sucrose10% sucrose corresponding to a regular soft drink
DRUGSucrose+ HesperetinAddition of hesperetin increases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution
OTHER7% Sucrose7% sucrose to match the caloric content of the sugar-reduced hesperetin intervention

Timeline

Start date
2024-03-31
Primary completion
2024-09-30
Completion
2024-11-15
First posted
2024-04-01
Last updated
2024-11-25

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT06340087. Inclusion in this directory is not an endorsement.